US IPO Weekly Recap: Bending Spoons Shines In IPO, While Cumberland Farms And Jersey Mike's Join The Pipeline

Three sizable IPOs and four SPACs priced this week, alongside 11 IPOs and four SPACs that filed. The near-term post–Independence Day calendar is mostly quiet, but a mega name is tentatively set to list next week. Research availability for five companies and lock-up expirations for three names are also key near-term catalysts, though no pricing or underwriting metrics were provided.

Analysis

This is less a catalyst for the broad market than a supply test for risk appetite. In a quiet post-holiday tape, even a modest cluster of new listings can siphon incremental demand away from existing growth names, especially in vehicles that own recent issuers or pre-IPO proxies such as the IPO ETF (IPO), ARKK, and small-cap growth baskets. The real question is whether the market can clear a few large deals without widening discounts in private-market comparables; that will tell us more about allocator risk budget than the raw count of filings.

Lock-up expiries matter more than the headline calendar because they create a 1-3 month overhang on float and a signaling event for insiders and early investors. If the market is already fatigued, these expiries can compress multiples in names with weak profitability or limited secondary liquidity, while reinforcing a relative bid for higher-quality profitable growth. For SPACs, continued issuance despite a mixed aftermarket implies the speculative bid is not dead, but it remains highly dependent on a benign first-day/first-week performance profile from the next marquee listing.

The contrarian read is that this is not a broad reopening, but a selection filter: only top-quartile assets may price well, while the rest get pushed into later windows or demand heavier discounts. If the tentative mega-name lists strongly, it could improve sentiment for 4-8 weeks and re-open the IPO window; if it trades poorly, expect a faster-than-expected reset in new-issue pricing and softer venture secondaries over the next quarter. The key falsifier is a strong aftermarket plus follow-on deal acceleration; absent that, treat this as a technical overhang, not a fundamental green light.

Key Decisions for Investors

• Keep a tactical underweight to IPO-sensitive beta (IPO, ARKK, IWM) until the first major listing prices and trades for 3-5 sessions; if the debut is weak, expect a 1-2 month de-risking window.
• If the marquee deal prints cleanly and holds gains, buy IPO/ARKK on the first post-listing pullback for a 4-8 week reopening trade; target a relative move versus QQQ, with a stop if the new issue breaks issue price by >10%.
• Use upcoming lock-up expiries as a short catalyst in unprofitable recent listings: fade names where post-lock-up float expands meaningfully and insider ownership is still high; cover into expiry if borrow tightens or secondary selling is minimal.
• Prefer profitable growth over unprofitable venture-backed names in this window: pair long quality software/Internet cash generators versus short basket exposure to the most recent IPO cohort, where multiple compression risk is highest.
• No aggressive options positioning until the mega-name ticker is known; treat current setup as an alert rather than a conviction trade, because the catalyst is supply-driven and highly dependent on deal quality.